Aadi Bioscience Correlations
AADI Stock | USD 2.34 0.06 2.63% |
The current 90-days correlation between Aadi Bioscience and Anebulo Pharmaceuticals is 0.08 (i.e., Significant diversification). The correlation of Aadi Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Aadi Bioscience Correlation With Market
Weak diversification
The correlation between Aadi Bioscience and DJI is 0.36 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and DJI in the same portfolio, assuming nothing else is changed.
Aadi |
Moving together with Aadi Stock
0.85 | VCYT | Veracyte | PairCorr |
0.74 | VERA | Vera Therapeutics | PairCorr |
0.65 | DRUG | Bright Minds Biosciences Trending | PairCorr |
0.64 | SABSW | SAB Biotherapeutics | PairCorr |
0.87 | VRNA | Verona Pharma PLC | PairCorr |
0.81 | VSTM | Verastem Trending | PairCorr |
Moving against Aadi Stock
0.92 | VALN | Valneva SE ADR | PairCorr |
0.78 | DRRX | Durect | PairCorr |
0.77 | ME | 23Andme Holding Upward Rally | PairCorr |
0.67 | DRMA | Dermata Therapeutics | PairCorr |
0.58 | VCNX | Vaccinex | PairCorr |
0.57 | DNTH | Dianthus Therapeutics | PairCorr |
0.45 | DOMH | Dominari Holdings | PairCorr |
0.36 | A | Agilent Technologies Sell-off Trend | PairCorr |
0.31 | EQ | Equillium | PairCorr |
0.88 | DTIL | Precision BioSciences | PairCorr |
0.85 | VINC | Vincerx Pharma | PairCorr |
0.81 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.8 | VTGN | VistaGen Therapeutics | PairCorr |
0.73 | VIRX | Viracta Therapeutics | PairCorr |
0.67 | VRAX | Virax Biolabs Group | PairCorr |
0.67 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.57 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.42 | VIGL | Vigil Neuroscience | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aadi Stock performing well and Aadi Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aadi Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ANEB | 4.86 | (0.19) | 0.00 | (0.01) | 0.00 | 8.61 | 76.00 | |||
ADAG | 4.38 | (0.15) | 0.00 | (0.54) | 0.00 | 8.13 | 37.93 | |||
ACRV | 2.87 | (0.45) | 0.00 | (0.13) | 0.00 | 7.66 | 22.84 | |||
ANAB | 3.46 | (0.86) | 0.00 | (0.14) | 0.00 | 5.77 | 35.57 | |||
MLYS | 2.71 | (0.16) | 0.00 | 0.06 | 3.42 | 6.27 | 20.98 | |||
ANTX | 2.25 | 0.55 | 0.19 | 0.70 | 1.69 | 6.00 | 28.03 | |||
AVTE | 2.44 | 0.45 | 0.18 | 0.60 | 2.04 | 5.58 | 19.11 | |||
GRCL | 5.71 | 1.72 | 0.18 | (0.60) | 6.35 | 16.34 | 52.11 | |||
THRX | 5.44 | (0.54) | 0.00 | 4.10 | 0.00 | 11.75 | 90.33 | |||
GLUE | 5.18 | 0.88 | 0.25 | 0.43 | 3.74 | 8.10 | 102.66 |
Aadi Bioscience Corporate Management
Neil Desai | President, Founder | Profile | |
Raymond Steitz | Senior Officer | Profile | |
Bryan Ball | Chief Operations | Profile | |
Marcy Graham | SVP Communications | Profile | |
Stephen JD | Senior Counsel | Profile | |
Brendan MBA | Chief Officer | Profile |